These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 402665)

  • 21. Involvement of brain histamine in delta 9-tetrahydrocannabinol tolerance and withdrawal.
    Verberne AJ; Fennessy MR; Lewis SJ; Taylor DA
    Pharmacol Biochem Behav; 1985 Aug; 23(2):153-9. PubMed ID: 2997805
    [TBL] [Abstract][Full Text] [Related]  

  • 22. delta 9-THC as a discriminative stimulus in rats and pigeons: generalization to THC metabolites and SP-111.
    Järbe TU; McMillan DE
    Psychopharmacology (Berl); 1980; 71(3):281-9. PubMed ID: 6256796
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 3H-delta9-tetrahydrocannabinol tissue and subcellular distribution in the central nervous system and tissue distribution in peripheral organs of tolerant and nontolerant dogs.
    Martin BR; Dewey WL; Harris LS; Beckner JS
    J Pharmacol Exp Ther; 1976 Jan; 196(1):128-44. PubMed ID: 1246007
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Delta-9-tetrahydrocannabinol: localization in body fat.
    Kreuz DS; Axelrod J
    Science; 1973 Jan; 179(4071):391-3. PubMed ID: 4682965
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reversal of SR 141716A-induced head-twitch and ear-scratch responses in mice by delta 9-THC and other cannabinoids.
    Janoyan JJ; Crim JL; Darmani NA
    Pharmacol Biochem Behav; 2002; 71(1-2):155-62. PubMed ID: 11812518
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tolerance to the effect of delta1-tetrahydrocannabinol on corticosterone levels in mouse plasma produced by repeated administration of cannabis extract or delta1-tetrahydrocannabinol.
    Pertwee RG
    Br J Pharmacol; 1974 Jul; 51(3):391-7. PubMed ID: 4451752
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of agonist-antagonist properties of nitrogen mustard and cyano derivatives of delta 8-tetrahydrocannabinol.
    Wiley JL; Compton DR; Gordon PM; Siegel C; Singer M; Dutta A; Lichtman AH; Balster RL; Razdan RK; Martin BR
    Neuropharmacology; 1996; 35(12):1793-804. PubMed ID: 9076759
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interaction between delta(9)-tetrahydrocannabinol and d-amphetamine.
    Hattendorf C; Hattendorf M; Coper H; Fernandes M
    Psychopharmacology (Berl); 1977 Oct; 54(2):177-82. PubMed ID: 412212
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Morphine and delta 9-tetrahydrocannabinol: two-way cross tolerance for antinociceptive and heart-rate responses in the rat.
    Hine B
    Psychopharmacology (Berl); 1985; 87(1):34-8. PubMed ID: 2997827
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 3'-Hydroxy- and (+/-)-3',11-dihydroxy-delta 9-tetrahydrocannabinol: biologically active metabolites of delta 9-tetrahydrocannabinol.
    Handrick GR; Duffley RP; Lambert G; Murphy JG; Dalzell HC; Howes JF; Razdan RK; Martin BR; Harris LS; Dewey WL
    J Med Chem; 1982 Dec; 25(12):1447-50. PubMed ID: 6296389
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tolerance to the effects of delta 1-tetrahydrocannabinol on the pressor responses to noradrenaline in rats.
    Li DM
    Clin Exp Pharmacol Physiol; 1981; 8(2):101-8. PubMed ID: 6265124
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A metabolic interaction in vivo between cannabidiol and 1 -tetrahydrocannabinol.
    Jones G; Pertwee RG
    Br J Pharmacol; 1972 Jun; 45(2):375-7. PubMed ID: 5048656
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cross-tolerance between inhaled cannabis and intraperitoneal injections of delta9-THC.
    Fried PA
    Pharmacol Biochem Behav; 1976 Jun; 4(6):635-8. PubMed ID: 981280
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cellular immune function in mice tolerant to or abstinent from l-trans-delta 9-tetrahydrocannabinol.
    Bhargava HN; House RV; Thorat SN; Thomas PT
    Pharmacology; 1996 May; 52(5):271-82. PubMed ID: 8807671
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Functional interaction and cross-tolerance between ethanol and Δ9-THC: possible modulation by mouse cerebellar adenosinergic A1/GABAergic-A receptors.
    Dar MS
    Behav Brain Res; 2014 Aug; 270():287-94. PubMed ID: 24875771
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sex difference in the oxidative metabolism of delta 9-tetrahydrocannabinol in the rat.
    Narimatsu S; Watanabe K; Yamamoto I; Yoshimura H
    Biochem Pharmacol; 1991 Apr; 41(8):1187-94. PubMed ID: 1848985
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Time-course of the effects of chronic delta 9-tetrahydrocannabinol on behaviour, body temperature, brain amines and withdrawal-like behaviour in the rat.
    Taylor DA; Fennessy MR
    J Pharm Pharmacol; 1982 Apr; 34(4):240-5. PubMed ID: 6124598
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Delta-9-tetrahydrocannabinol (THC) affects forelimb motor map expression but has little effect on skilled and unskilled behavior.
    Scullion K; Guy AR; Singleton A; Spanswick SC; Hill MN; Teskey GC
    Neuroscience; 2016 Apr; 319():134-45. PubMed ID: 26826333
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of Delta 9-tetrahydrocannabinol, (R)-methanandamide, SR 141716,and d-amphetamine before and during daily Delta 9-tetrahydrocannabinol dosing.
    Lamb RJ; Järbe TU; Makriyannis A; Lin S; Goutopoulos A
    Eur J Pharmacol; 2000 Jun; 398(2):251-8. PubMed ID: 10854837
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biphasic effects of Δ9-tetrahydrocannabinol on brain stimulation reward and motor activity.
    Katsidoni V; Kastellakis A; Panagis G
    Int J Neuropsychopharmacol; 2013 Nov; 16(10):2273-84. PubMed ID: 23830148
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.